January 4, 2024 03:11 PM EST

Revance loses attempt to dismiss Botox trade secrets lawsuit

Nicole DeFeudis

Editor

A Tennessee federal judge on Wednesday declined to dismiss a trade secrets lawsuit against Revance Therapeutics, which launched a Botox rival in 2022 and is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Revance loses attempt to dismiss Botox trade secrets lawsuit

Nicole DeFeudis

Editor

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Updated: CDER Director Patrizia Cavazzoni to step down ahead of Trump presidency

Exclusive: First-of-its-kind infant DNA edit leads to apparent cure in disease that set back field 25 years ago

Exclusive: Jim Wilson startup gets FDA green light for first test of gene editing in babies

Biogen offers to buy out struggling neuro partner Sage Therapeutics

In surprise move, FDA's No. 2 Bumpus to leave agency at end of 2024

Exclusive: Moderna's former top scientist has a new startup using AI to improve mRNA therapies

Re­vance los­es at­tempt to dis­miss Botox trade se­crets law­suit

Editor

Sign up to read this article for free.

more like this

Bachem

Bubendorf, BL, Switzerland

Revance loses attempt to dismiss Botox trade secrets lawsuit